Updated just now · Live
Stock analysis, price data, and AI-powered insights for Lyell Immunopharma Inc (LYEL).
Lyell Immunopharma Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for LYEL.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). LYEL Stock Intelligence Report. [stoxpulse.com/stocks/lyel]
Disclaimer: The information on this page about Lyell Immunopharma Inc (LYEL) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Lyell Immunopharma Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Lyell Immunopharma, Inc. (LYEL) Presents at 25th A...
4d ago
Transcript : Lyell Immunopharma, Inc. Presents at ...
4d ago
StoxPulse AI results for LYEL: Pulse Score 42/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$580.1M
P/E Ratio
—
EPS
$-2.13
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Transcript : Lyell Immunopharma, Inc. Presents at 25th Annual Needham Virtual Healthcare Conference, Apr-14-2026 11
A First Look At Lyell Immunopharma